21 April 2008 - BioGaia has signed a distribution agreement with the Belgium company NeoCare which gives NeoCare rights to sell BioGaia's Probiotic drops and tablets in Belgium and Luxembourg. The products will be sold under BioGaia's trademark.
NeoCare is a pharmaceutical company, operational in Belgium, building a unique partnership philosophy in the choice of products which are generally recognised for their absolute and proven top quality.
”The agreement with NeoCare proves that we have a very competitive product portfolio appealing to companies with focus on pharmacies and health care stakeholders”, says PR President BioGaia AB.
”The products will be the first probiotic product-range in Belgium and Luxembourg, offered under the special pharmaceutical form of drops (indicated for infants) and chewable tablets”, says Jef Hus, General Manager NeoCare.